Eugenio Battaglia

Eugenio Battaglia

Oct 17, 2014

Group 6 Copy 209
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Living Skin Therapeutics

    One of the biggest roadblocks to having clear skin is acne, and despite all the effective treatment options...

    Can a Meal Replacement Help Solve Hunger in America?

    In the United States, hunger is commonplace. 42 million Americans struggle to get the healthy foods they need...

    Crowdcuring the Blues: People, Technology and Research Against Depression

    Depression is not a choice, but we can choose to do something about it. Depression is a single label used...

    Backer Badge Funded